A phase I/II study of EYS606 for the treatment of non-infectious uveitis (NIU)

Trial Profile

A phase I/II study of EYS606 for the treatment of non-infectious uveitis (NIU)

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 09 May 2017

At a glance

  • Drugs EYS 606 (Primary)
  • Indications Uveitis
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 09 May 2017 Professor Antoine Brezin is the principal investigator of the trial, according to an Eyevensys media release,
    • 09 May 2017 According to an Eyevensys media release, the first patient has been successfully treated in this trial and initial trial results are expected in the first half of 2018.
    • 09 May 2017 Status changed from planning to recruiting, according to an Eyevensys media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top